Celgene presents data from PALACE 3 study Celgene International Sàrl, a wholly-owned subsidiary of Celgene, announced results from PALACE 3, the company’s third phase III study in psoriatic arthritis, or PsA, at EULAR, the European Congress of ...
June 13, 2013 - Theflyonthewall.com via Yahoo! Finance